SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla - Quaterly Results

25 Jul 2025 Evaluate
The Revenue for the quarter ended  June 2025 of Rs. 50461.70 millions grew by 12.11 % from Rs. 45010.50 millions.Profit saw a slight increase of 23.41%to Rs. 13031.30  millions from Rs. 10559.40 millions.Operating Profit saw a handsome growth to 18955.20 millions from 15733.80 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 50461.70 45010.50 12.11 50461.70 45010.50 12.11 190448.50 165743.40 14.91
Other Income 2710.70 2135.20 26.95 2710.70 2135.20 26.95 9847.20 10706.60 -8.03
PBIDT 18955.20 15733.80 20.47 18955.20 15733.80 20.47 67631.60 55548.10 21.75
Interest 58.80 50.70 15.98 58.80 50.70 15.98 151.10 202.50 -25.38
PBDT 18896.40 15683.10 20.49 18896.40 15683.10 20.49 70427.10 55345.60 27.25
Depreciation 1456.90 1378.60 5.68 1456.90 1378.60 5.68 5738.90 5875.90 -2.33
PBT 17439.50 14304.50 21.92 17439.50 14304.50 21.92 64688.20 49469.70 30.76
TAX 4408.20 3745.10 17.71 4408.20 3745.10 17.71 13111.70 12327.80 6.36
Deferred Tax -152.20 165.90 -191.74 -152.20 165.90 -191.74 -491.50 60.90 -907.06
PAT 13031.30 10559.40 23.41 13031.30 10559.40 23.41 51576.50 37141.90 38.86
Equity 1615.50 1615.00 0.03 1615.50 1615.00 0.03 1615.20 1614.70 0.03
PBIDTM(%) 37.56 34.96 7.46 37.56 34.96 7.46 35.51 33.51 5.96

Cipla Share Price

1238.30 7.55 (0.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×